Monday, July 07, 2014

Cosmetic Surgery Stocks are Looking Good

Over 75% of all people in the US have passed the age of 55, and they are looking for ways to reduce the aging process, whether naturally or artificially.

The Growth of the Cosmetic Surgery Industry

Over 3 million of those Americans have some form of cosmetic procedure each year. There have been significant strides in all types of cosmetic surgery procedures, that are now significantly quicker, safer, and with a quicker recovery period.

 There are about ten cosmetic surgery product companiest available to investors,  according to the free list at Some of these companies have no debt with lots of cash.

The Stock that Tripled in the Last Year and a Half

A perfect example is ZELTIQ Aesthetics (ZLTQ), which makes non-invasive products for the reduction of fat. Its primary product is the CoolSculpting System. The stock has gone from 5 a share in January of last year to almost 15 a share now. Actually the stock reached almost 25 a share in January of this year, so it has had a bit of a sell-off. Although the company is currently generating negative earnings, revenues spiked by 55% for the latest reported quarter.  One of the best features about the company is that it is debt free with $33 million in the bank.

More Cosmetic Surgery Stocks

Cynosure (CYNO) sells the  Smartlipo® LaserBodySculpting™ Workstations for treating localized fat deposits using a minimally invasive technique. The company also markets laser systems to treat cellulite, including Cellulaze, SmoothShapes XV, and Triactive. Another product is PicoSure, a picosecond instrument to remove tattoos. The stock trades at 14 times forward earnings. Revenues for the latest reported quarter jumped by 52%, although earnings dropped. The company has $121 million in cash amounting to $5.44 in cash per share.

PhotoMedex (PHMD) makes XTRAC laser products for psoriasis and vitiligo, NEOVA for premature skin aging, and Omnilux Light-emitting diode for wrinkles and acne. The stock has a price to earnings ratio of 23  and a forward PE of 15. It has $48 million in cash, with $2.57 in cash per share. Revenues declined 22.5% for the latest quarter.

Additional 'Looking Good' Stocks

To access a free list of the cosmetic surgery stocks, and stocks in related industries, go to The list includes the trailing PE, the forward PE, the yield, and the business.

Disclosure: Author did not own any of the above at the time the article was written.


No comments: